Pfizer RSV vaccine given to pregnant mothers protects newborns, company data shows

Pfizer RSV vaccine given to pregnant mothers protects newborns, company data shows

Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to mothers late in their pregnancy, according to clinical trial data released Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, but it can be dangerous for infants under 6 months of … Read more

Pfizer’s earnings are Tuesday. What to see.

Pfizer’s earnings are Tuesday.  What to see.

Pfizer is set to report earnings on Tuesday, a week and a half after an executive told investors the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per adult dose, higher than analysts had expected. The surprise has prompted analysts to rethink their estimates for next year’s Covid-19 … Read more

Long Covid affects women more than men, a national study shows

Long Covid affects women more than men, a national study shows

A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sports stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long-term … Read more

Pfizer, Uber and Starbucks Highlight Another Busy Earnings Week

Pfizer, Uber and Starbucks Highlight Another Busy Earnings Week

Pfizer Inc., PFE 3.69% Uber UBER -1.15% Technologies Inc. and Starbucks Corp. SBUX 2.13% are among the heavyweights headlining another busy earnings week as investors search for insight into the state of the broader economy. Nearly a third of the S&P 500, or about 160 component companies, is slated to report earnings in the coming week, according to … Read more

Omicron subvariants resistant to key antibody treatments are increasing

Omicron subvariants resistant to key antibody treatments are increasing

Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of … Read more

FDA sees limits to omicron-booster studies from Columbia, Harvard

FDA sees limits to omicron-booster studies from Columbia, Harvard

The Food and Drug Administration said two studies this week showing that the new omicron boosters weren’t that much better than the old shots were too small to come to any real conclusions. Scientists at Columbia and Harvard, in two independent studies, found the new boosters and the old shots basically performed the same against … Read more

New Covid booster shots do not protect better against omicron BA.5, studies show

New Covid booster shots do not protect better against omicron BA.5, studies show

The new COVID-19 booster that includes protection for Omicron at AltaMed Health Services in South Gate on Thursday, October 6, 2022. Sarah Reingewirtz | MediaNews Group | Los Angeles Daily News via Getty Images Two studies cast doubt on whether the new omicron BA.5 booster will really provide better protection against Covid than the first … Read more

Omicron subvariants show resistance, putting some people at risk

Omicron subvariants show resistance, putting some people at risk

New omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter, the White House warned this week. “With some of the new subvariants emerging, some of the main tools we’ve had to protect the immunocompromised like Evusheld may not … Read more

We must chart our own path on biotechnology away from geopolitics

We must chart our own path on biotechnology away from geopolitics

Columnists We must chart our own path on biotechnology away from geopolitics Wednesday 26 October 2022 An abstract depiction of the genetic engineering of maize. FILE PHOTO | POOL As the debate over the pros and cons of the government’s decision to lift the moratorium on genetically modified food and feed products, it is important … Read more

People who had mild Covid had increased risk of blood clots: UK study

People who had mild Covid had increased risk of blood clots: UK study

A patient receives a coronavirus disease (COVID-19) test at Sparrow Laboratories Drive-Thru Services in Lansing, Michigan, on Dec. 27, 2021. Emily Elconin | Reuters People who contracted mild cases of Covid-19 during the first year of the pandemic had a higher risk of developing blood clots than those who were not infected, according to a … Read more